RAD 2020 Abstracts - Page 3


#166 - Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Phase 3, JADE MONO-1 Study

EL Simpson, R Sinclair, S Forman, A Wollenberg, R Asch, M Cork, T Bieber, JP Thyssen, G Yosipovitch, N Magnolo, C Maari, C Flohr, C Feeney, P Biswas, S Tatulych, H Valdez, R Rojo

#167 - Predictors of Maintenance of Response in Patients With Moderate-to-Severe Atopic Dermatitis After Oral Janus Kinase 1 Selective Inhibitor Abrocitinib Interruption

MJ Gooderham, G Girolomoni, JO Moore, JI Silverberg, M Curto5, W Zhang, M DiBonaventura, H Valdez

#171 - Epidemiology of Atopic Dermatitis (AD) in Children Aged 6–11 Years: A Cross-Sectional Study in the United States (US), Canada, Europe, and Japan

Jonathan I. Silverberg, Sebastien Barbarot, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina-Osorio, Lysel Brignoli, Grece Saba, Miriam C. Fenton, Laurent Eckert

#172 - A Multidisciplinary Assessment of Shared Decision Making in Atopic Dermatitis

Wendy Smith Begolka, L Butler, SBender, D Dietze

#173 - Measurement properties of Patient Health Questionnaire-9 in adult patients 1 with atopic dermatitis

Brad Lee, BS, Donald Lei, MS, Muhammad Yousaf, BS, Sherief R. Janmohamed, MD, PhD, Paras P. Vakharia, MD, PharmD, Rishi Chopra, MD, MS, Rajeev Chavda, MD, Sylvie Gabriel, MD, Kevin R. Patel, M9, Vivek Singam, MD, Robert Kantor, MD, Derek Y. Hsu, MD, Jonathan I. Silverberg, MD, PhD, MPH

#175 - Evaluating the longitudinal course of sleep disturbance in atopic dermatitis

JI Silverberg, M Hong

#177 - Epidemiology of atopic dermatitis (AD) in children aged 6–11 years: a cross-sectional study in the United States (US), Canada, Europe, and Japan

Jonathan I Silverberg, Sebastien Barbarot, Abhijit Gadkari, Eric L Simpson, Stephan Weidinger, Paola Mina-Osorio, Lysel Brignoli, Grece Saba, Miriam C Fenton, Laurent Eckert

#178 - Evaluating the longitudinal course of atopic dermatitis severity in clinical practice

JI Silverberg, M Hong

#179 - Measurement properties of the product of investigator’s global assessment and body surface area in children and adults with atopic dermatitis

JI Silverberg, D Lei, M Yousaf, SR. Janmohamed, PP Vakharia, R Chopra, R Chavd, S Gabriel, KR Patel, V Singam, R Kantor, DY Hsu

#182 - What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis? A prospective clinical study

JI Silverberg, D Lei, M Yousaf, SR Janmohamed, PP Vakharia, R Chopra, R Chavda, S Gabriel, KR Patel, V Singam, R Kantor, DY Hsu

#183 - Measurement properties of four patient-reported outcome measures to assess sleep disturbance in adults with atopic dermatitis

DK Lei, M Yousaf, SR Janmohamed, PP Vakharia, R Chopra, R Chavda, S Gabriel, R Sacotte, KR Patel, V Singam, R Kantor, DY Hsu, D Cella, JI Silverberg

© 2020 The Foundation for Dermatology Education.
The Foundation for Dermatology Education is a registered 501(c)(3) nonprofit organization located in Chicago, IL.